Healthcare Providres Dr Avidual Public Offer (IPO) element of Bidding, January 30. The IPO, Combination. (Of) of Rs 2,727 crore. On the first day, the issue was registered for a total of 7 percent, 38.2.charting shares against $ 5.35 crore on the offer, according to the temporary exchange information.
And on the first three-day bidding process, components set for non-provincial investors and investors have registered 6 percent and 11 percent, while in terms of information.
Here are 5 important things to know about Dr Agarwal Health Care IPO:
Important days: The problem opened by subscription Wednesday and will close on Friday. The bidding will continue to be found between 10am and 5 pm up to Friday.
The price of the problem: Under the IPO, stocks are available for bidding between Rs 382 and Rs 402.
Lot size: Bids can be placed on multiple stocks of 35.
Day Date: The stock may be listed on February 5.
Company Profile: The company offers various eye care services, including the cataract and unloving surgery, consultation, diagnosis, insolent, insecure treatment. It also includes optical products, communications lenses, accessories, and many drug items.
Should you apply for Dr. Agarwal Health Care Post Office? Here’s what Market Guru Anil Singhvi thinks
According to Zee Business Oper Open Editor Anil Anil Singhvi, only the best investors should consider registering.
Pointed to the following key points in the market in the market:
True
- Proponents are informed and experts.
- The company has a strong type and place of leadership in the market.
- Its business runs to the property light model.
- The company also allowed the Anchor investors.
Negative
- There are low barriers to enter into business.
- The part is full of intense competition.
- Despite being an old company, its business development only takes once recently.
- The new part of the matter is too small in comparison with the OFS.
- Its estimation looks costing peers visited by the industry.
Before the IPO launch, health care company RS 875.5 crore from Angel investors.
